Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.

Iams WT, Beckermann KE, Almodovar K, Hernandez J, Vnencak-Jones C, Lim LP, Raymond CK, Horn L, Lovly CM
J Thorac Oncol. 2019 14 (3): e45-e48

PMID: 30543839 · PMCID: PMC6382512 · DOI:10.1016/j.jtho.2018.11.031

MeSH Terms (13)

Adenocarcinoma of Lung Aged Antineoplastic Agents, Immunological Cell Transformation, Neoplastic Drug Resistance, Neoplasm Female Humans Lung Neoplasms Mutation Prognosis Programmed Cell Death 1 Receptor Proto-Oncogene Proteins p21(ras) Small Cell Lung Carcinoma

Connections (1)

This publication is referenced by other Labnodes entities: